Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Douer

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Best Practice & Research. Clinical Haematology|August 26, 2003
The epidemiology of acute promyelocytic leukaemiaDan Douer
Acta Haematologica|June 26, 2013
Adult acute lymphoblastic leukemia: a cancer with no standard of careDan Douer
Best Practice & Research. Clinical Haematology|December 4, 2012
What is the impact, present and future, of novel targeted agents in acute lymphoblastic leukemia?Dan Douer
The Oncologist|June 23, 2016
Efficacy and Safety of Vincristine Sulfate Liposome Injection in the Treatment of Adult Acute Lymphocytic LeukemiaDan Douer
Best Practice & Research. Clinical Haematology|December 2, 2008
Is asparaginase a critical component in the treatment of acute lymphoblastic leukemia?Dan Douer
International Journal of Hematology|November 15, 2002
New advances in the treatment of acute promyelocytic leukemiaDan Douer
Acta Haematologica|January 31, 2002
Advances in the treatment of relapsed acute promyelocytic leukemiaDan Douer
Best Practice & Research. Clinical Haematology|December 3, 2014
Will novel agents for ALL finally change the natural history?Dan Douer
Blood|January 25, 2020
How I treat the toxicities of pegasparaginase in adults with acute lymphoblastic leukemiaIbrahim Aldoss, Dan Douer
Best Practice & Research. Clinical Haematology|June 8, 2014
Extramedullary disease in APL: a real phenomenon to contend with or not?Chezi Ganzel, Dan Douer
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Best Practice & Research. Clinical Haematology|August 26, 2003
The epidemiology of acute promyelocytic leukaemiaDan Douer
Acta Haematologica|June 26, 2013
Adult acute lymphoblastic leukemia: a cancer with no standard of careDan Douer
Best Practice & Research. Clinical Haematology|December 4, 2012
What is the impact, present and future, of novel targeted agents in acute lymphoblastic leukemia?Dan Douer
The Oncologist|June 23, 2016
Efficacy and Safety of Vincristine Sulfate Liposome Injection in the Treatment of Adult Acute Lymphocytic LeukemiaDan Douer
Best Practice & Research. Clinical Haematology|December 2, 2008
Is asparaginase a critical component in the treatment of acute lymphoblastic leukemia?Dan Douer
International Journal of Hematology|November 15, 2002
New advances in the treatment of acute promyelocytic leukemiaDan Douer
Acta Haematologica|January 31, 2002
Advances in the treatment of relapsed acute promyelocytic leukemiaDan Douer
Best Practice & Research. Clinical Haematology|December 3, 2014
Will novel agents for ALL finally change the natural history?Dan Douer
Blood|January 25, 2020
How I treat the toxicities of pegasparaginase in adults with acute lymphoblastic leukemiaIbrahim Aldoss, Dan Douer
Best Practice & Research. Clinical Haematology|June 8, 2014
Extramedullary disease in APL: a real phenomenon to contend with or not?Chezi Ganzel, Dan Douer
Pageof 9